You're sitting in a consultation room in Columbia with two very reasonable goals. You want smoother frown lines, but you also want to know whether Daxxify's longer duration is useful or makes a result harder to change. The right answer depends less on which product sounds newer and more on how you live, what area you're treating, and how comfortable you are waiting for an unwanted result to fade.
Table of Contents
- Two Patients, Two Choices
- What Daxxify and Botox Actually Are
- Head-to-Head on Onset, Duration, and Dosing
- Side Effects, Safety, and the Reversibility Question
- Cost, Frequency, and the Real Annual Math
- Choosing the Right Product for You
- How to Decide and What to Do Next
Two Patients, Two Choices
One patient comes in before a busy wedding season. Work travel, family events, and appointments already fill the calendar. She's used Botox before, likes the result, and mainly wants fewer maintenance visits. For her, a longer-lasting option may make sense, provided she's comfortable committing to the same general result for a longer period.
Another patient is preparing for a major life change and has never tried a neuromodulator. She wants a subtle improvement, not a dramatic shift, and she'd rather have the ability to adjust the plan regularly. I'd usually favor the more familiar, shorter-acting route for that first experiment. She isn't asking for maximum duration. She's asking for control.
That distinction matters. In the consult room, “Which lasts longer?” is rarely the only question. Patients are usually asking:
- How many appointments will I need?
- What happens if I don't like the shape of my brows?
- Can we change the dose next time?
- Will this product fit the area I want treated?
- Am I paying for convenience or paying more per visit?
Botox Cosmetic was first approved by the U.S. FDA for temporary improvement of moderate to severe glabellar lines in adults under 65 on April 12 to 15, 2002, and its original label described effects lasting up to 120 days, or about four months. The approval followed Botox's earlier medical use, which began in 1989. The FDA approval letter provides that regulatory context.
Daxxify was approved in September 2022, with the SAKURA Phase 3 program including more than 2,700 patients and approximately 4,200 treatments. The approval announcement reported a median duration of effect of 24 weeks, with some patients maintaining results up to nine months.
My initial recommendation is simple. Choose the product that matches your tolerance for commitment, not the one with the most impressive headline.
What Daxxify and Botox Actually Are
Botox Cosmetic and Daxxify are both prescription neuromodulators made from botulinum toxin type A. They temporarily reduce the nerve signal that tells a targeted muscle to contract. With less muscle activity, expression lines can soften.
Botox Cosmetic contains onabotulinumtoxinA. Daxxify contains daxibotulinumtoxinA-lanm. Daxxify uses a peptide-based stabilizing and delivery approach, while Botox uses a different formulation system. You don't need to understand the molecular details to make a good decision, but you should understand that their treatment units aren't interchangeable.
The shared mechanism is the clinically important part. Both products act at the neuromuscular junction by interfering with acetylcholine release. The result is temporary chemical denervation of the treated muscle, not permanent muscle removal and not a filler effect. They won't restore lost volume or improve skin texture in the same way as a filler or resurfacing treatment.
Daxxify's approved cosmetic indication is specific. It was studied and approved for glabellar lines, the vertical lines between the eyebrows. That matters because online comparisons often treat its duration as if it applies identically to every facial area. It doesn't. Your injector still has to decide whether the product is appropriate for your anatomy, muscle pattern, and treatment goal.
| Attribute | Daxxify | Botox |
|---|---|---|
| Active ingredient | DaxibotulinumtoxinA-lanm | OnabotulinumtoxinA |
| Cosmetic FDA approval | Approved in September 2022 for glabellar lines | Approved in April 2002 for temporary improvement of glabellar lines |
| Mechanism | Temporarily reduces nerve-to-muscle signaling | Temporarily reduces nerve-to-muscle signaling |
| Main distinction | Longer median duration for glabellar lines | Longer-established cosmetic track record |
| Unit comparison | Units are product-specific | FDA labeling specifies 20 Units for glabellar lines |
| Best decision lens | Convenience versus longer commitment | Precision, familiarity, and easier adjustment |
For a treatment-specific overview, visit Daxxify treatment in Columbia. The important takeaway is that these are related medicines, not interchangeable versions of the same vial.
Head-to-Head on Onset, Duration, and Dosing
The useful comparison has four parts: onset, duration, dosing, and fit. Trial averages provide a starting point, but facial movement, muscle strength, metabolism, and treatment area shape the actual result. In the consult room, I focus less on the longest number in a brochure and more on how much scheduling flexibility and reversibility you want.
Onset is helpful, but do not schedule around a promise
Daxxify's prescribing information says its cosmetic effect can begin one to two days after injection and build during the first week. Botox's FDA label also describes chemical denervation beginning in one to two days, while visible improvement may develop more gradually in routine treatment. A plastic surgery trade publication summarizes the practical difference as one to two days for Daxxify versus 10 to 14 days for Botox onset. That comparison is useful, but I advise patients to allow the result to settle before evaluating it.
Duration gives Daxxify its clearest advantage
The Botox Cosmetic FDA label states that results for glabellar lines last approximately three to four months. It also says safety and effectiveness for treatment more often than every three months have not been clinically evaluated. The Botox label supports that interval guidance. For more context on Botox's expected timeline, see how long Botox lasts.
Daxxify studies reported a median duration of 24 weeks, about six months, with some patients maintaining results up to nine months. In a Phase 2 comparison, median response lasted 24 weeks for Daxxify and 19 weeks for Botox, a difference of roughly five weeks for that glabellar-line indication. The comparative discussion connects those findings to retreatment planning.
| Criterion | Daxxify | Botox |
|---|---|---|
| Onset | Can begin in one to two days, with intensity increasing during the first week | Chemical denervation begins in one to two days, with visible improvement often taking longer |
| Median duration for glabellar lines | 24 weeks, about six months | Approximately three to four months according to the FDA label |
| Longer responses | Some patients maintained results up to nine months | Original cosmetic labeling described effects lasting up to 120 days |
| Dosing units | Product-specific units that should not be compared directly with Botox units | FDA label specifies 20 Units for glabellar lines |
| Practical strength | Longer maintenance cycle | More frequent opportunities to refine the plan |
Dosing creates unnecessary confusion. A larger Daxxify unit count does not mean a stronger treatment, and a smaller Botox number does not mean a weaker one. The Botox prescribing label specifies 20 Units in 0.5 mL for glabellar lines, but each product uses its own unit convention. Compare plans by expected result, treatment area, and cost, never by raw units alone.
Practical rule: A unit is meaningful only within the product that defines it.
Side Effects, Safety, and the Reversibility Question
A patient who wants a subtle first treatment and another who prioritizes fewer appointments should not receive the same counseling. Both products require a careful medical history and an injector who understands anatomy, muscle balance, dose, placement, and the treatment area. The injection is quick. The result is shaped by those decisions, and a longer-lasting product changes how long you may live with an unwanted outcome.
Public regulatory materials for Daxxify report injection-site reactions in 9% of subjects, headache in 6%, eyelid ptosis in 2%, and facial paresis or asymmetry in 1%. No serious treatment-related adverse events were reported in the core aesthetic trials. The reported Daxxify safety data should be considered with the full prescribing information and your medical history.
| Factor | Daxxify | Botox |
|---|---|---|
| Injection-site reactions | Reported in key clinical trials, including a 9% rate in public regulatory summaries | Can include localized injection-site effects |
| Headache | 6% in the cited clinical-trial summary | Recognized possible adverse reaction |
| Eyelid ptosis | 2% in the cited clinical-trial summary | Recognized possible adverse reaction |
| Facial paresis or asymmetry | 1% in the cited clinical-trial summary | Recognized possible adverse reaction |
| Distant toxin spread | Rare but serious warning applies | Rare but serious warning applies |
| Reversibility | Wears off naturally, but the longer duration can extend dissatisfaction | Wears off naturally, usually over a shorter maintenance cycle |
The question patients often skip is reversibility tolerance. Neither product can be switched off immediately if you dislike your brow position, smile balance, or remaining forehead movement. An injector may be able to make adjustments in some cases, but the medication's effect still has to fade. If Daxxify lasts about six months for you, an unfavorable result can affect your confidence and convenience for longer than the same issue during a shorter Botox cycle.
Tell your injector about neuromuscular conditions, swallowing or breathing problems, previous reactions, medications, pregnancy or plans for pregnancy, and breastfeeding. Discuss the treatment area, too. A product that suits glabellar lines may not be the right fit for every area or aesthetic goal.
A first-time patient seeking conservative changes may reasonably choose Botox on purpose. That choice reflects tolerance for reversibility, not fear. If you prefer more opportunities to reassess muscle movement and refine the plan, the shorter commitment can matter more than maximum duration.
Cost, Frequency, and the Real Annual Math
I won't pretend there's a universal annual price. Your total depends on the treatment areas, dose, provider pricing, touch-up policy, and any loyalty or membership pricing available at the practice. The honest comparison is not “Which vial costs less?” It's what does the maintenance plan look like over a year?
For glabellar lines, Botox's FDA-labeled dose is 20 Units, with an expected duration of approximately three to four months. That commonly creates a maintenance pattern of roughly three or four visits in a year, although your injector may recommend a different schedule based on your response. Daxxify's results support a median duration of 24 weeks, which can mean closer to two maintenance visits for some patients.
| Cost Factor | Daxxify | Botox |
|---|---|---|
| Per-visit price | May be higher depending on the practice and plan | May be lower per visit depending on the practice and plan |
| Typical glabellar-line cadence | Often fewer visits when the longer duration applies | Often more frequent maintenance visits |
| Unit comparison | Units aren't interchangeable with Botox units | FDA-labeled glabellar-line dose is 20 Units |
| Annual total | Depends on duration, dose, and pricing | Depends on dose, visit frequency, and pricing |
| Biggest variables | Individual longevity, treatment scope, touch-ups, loyalty pricing | Individual longevity, treatment scope, touch-ups, loyalty pricing |
The arithmetic can surprise people. A Daxxify visit may cost more, but fewer appointments can bring the yearly total closer to Botox than the per-treatment price suggests. The opposite can also happen if you need a higher dose, treat multiple areas, or don't personally receive the longer duration reported in trials.
Use the practice's actual estimate rather than an internet average. This guide to Botox cost can help you understand the questions to ask, but your written plan should identify the areas, proposed dose, expected cadence, and what happens if a touch-up is needed.
Choosing the Right Product for You
The right choice depends on your treatment history, target area, schedule, and tolerance for a result that takes longer to fade. Product longevity matters, but annual convenience and reversibility matter just as much.
Botox is usually the better starting point for a first-time patient. You can see how your face responds, decide how much movement you prefer, and adjust the next plan after the result settles. It also fits patients treating a small, precise area, such as a subtle lip flip or bunny lines, when controlled refinement matters more than the longest possible duration.
Botox also suits patients who want regular opportunities to reassess. If you are changing jobs, preparing for an event, or still deciding between a softer and more mobile result, a shorter maintenance cycle gives you more chances to change the dose and technique.
Daxxify is a stronger fit for an experienced patient who already knows the look they want. If neuromodulators have given you a reliable result and your main frustration is returning for maintenance, a longer-lasting profile may reduce appointment burden. Frequent travelers and busy professionals may also prefer consolidating visits, provided they accept the longer wait for an unwanted result to fade.
My candid recommendation: Don't make Daxxify your first experiment because six months sounds better than four. Make it your next experiment after you know the result you want and can tolerate a longer commitment.
Treatment-area fit remains decisive. Daxxify was studied and approved for glabellar lines, so your consultation should address whether it suits the forehead, crow's feet, or a smaller zone. Muscles respond differently by area. Longer duration does not replace precise placement or a plan for how much movement you want to retain.
Use this filter:
- Choose Botox if you are new, want frequent adjustments, prefer a lower-commitment trial, or need a small, precise treatment.
- Consider Daxxify if you have used neuromodulators before, prioritize fewer appointments, and accept that an unwanted result may take longer to fade.
- Ask about both if your schedule, budget, or treatment area does not fit neatly into either profile.
How to Decide and What to Do Next
Before booking, answer three questions.
Start with your tolerance for duration
Do you want the longest maintenance interval available for the indication being treated, or do you want more frequent chances to refine the result? If convenience is the priority and you already know your preferred look, Daxxify deserves serious consideration. If you're uncertain, Botox gives you a shorter feedback loop.
Identify the treatment area
Are you treating the glabella, forehead, crow's feet, or a smaller zone? Daxxify's cosmetic approval and strongest evidence center on glabellar lines, so don't assume its duration transfers perfectly to every area. Your injector should assess muscle strength, brow position, asymmetry, and how much movement you want to preserve.
Compare the complete plan
Do you prefer a lower per-treatment price, or would fewer appointments fit your annual budget and schedule better? Ask for both options in writing. The estimate should show the proposed areas, product, dose, expected maintenance cadence, and touch-up policy.
| Your priority | My starting recommendation |
|---|---|
| First treatment | Botox |
| Small, highly precise area | Botox |
| More frequent dose adjustments | Botox |
| Fewer annual appointments | Daxxify |
| Proven response and known preferred dose | Daxxify |
| Uncertainty about tolerating a longer result | Botox |
At ProMD Health Columbia, you can schedule a complimentary consultation to discuss Botox or Daxxify treatment. Bring your current medication list, previous neuromodulator history, and a clear description of what you want to change. Expect a facial assessment and dosing discussion, not pressure to receive an injection before you understand the plan.
Ask the team to price both options for your actual treatment areas. Don't choose from a social media post, chase duration without considering injector experience, or skip the conversation about longevity versus reversibility.
If you're in Columbia, Ellicott City, Clarksville, Laurel, or the surrounding Howard County area, schedule the consult before choosing a product. ProMD Health Columbia offers Botox and Daxxify with treatment planning based on your facial anatomy, goals, and preferred maintenance rhythm. Visit ProMD Health Columbia to request your consultation and compare both options in person.
